InvestorsHub Logo
Followers 30
Posts 2386
Boards Moderated 0
Alias Born 04/10/2014

Re: None

Thursday, 09/11/2014 12:44:30 PM

Thursday, September 11, 2014 12:44:30 PM

Post# of 5918
GWPH preference to go for FDA approval for Sativex as a backup to opiates which do not provide pain relief is a good move.Limited patient numbers and take up is more likely to get approval .Which will then open the door for re-classification or approval of all their other cannabis based formulas